| __timestamp | ACADIA Pharmaceuticals Inc. | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 60602000 | 19586000 |
| Thursday, January 1, 2015 | 73869000 | 29135000 |
| Friday, January 1, 2016 | 99284000 | 42791000 |
| Sunday, January 1, 2017 | 149189000 | 49577000 |
| Monday, January 1, 2018 | 187163000 | 89209000 |
| Tuesday, January 1, 2019 | 240385000 | 69099000 |
| Wednesday, January 1, 2020 | 319130000 | 75961000 |
| Friday, January 1, 2021 | 239415000 | 90467000 |
| Saturday, January 1, 2022 | 361575000 | 74552000 |
| Sunday, January 1, 2023 | 351619000 | 91593000 |
Infusing magic into the data realm
In the competitive world of pharmaceuticals, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, ACADIA Pharmaceuticals Inc. and Supernus Pharmaceuticals, Inc. have demonstrated contrasting strategies in their R&D investments.
From 2014 to 2023, ACADIA Pharmaceuticals has consistently increased its R&D spending, peaking in 2022 with a remarkable 500% increase from its 2014 levels. This aggressive investment underscores ACADIA's strategic focus on pioneering new treatments and expanding its product pipeline. In contrast, Supernus Pharmaceuticals has maintained a more conservative approach, with R&D expenses growing by approximately 370% over the same period.
This divergence in R&D spending highlights the different paths these companies are taking to secure their future in the ever-evolving pharmaceutical landscape. As ACADIA bets on breakthrough innovations, Supernus balances its R&D investments with other strategic priorities.
Research and Development: Comparing Key Metrics for Novo Nordisk A/S and Supernus Pharmaceuticals, Inc.
R&D Spending Showdown: Novartis AG vs ACADIA Pharmaceuticals Inc.
Gilead Sciences, Inc. vs ACADIA Pharmaceuticals Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Regeneron Pharmaceuticals, Inc. and ACADIA Pharmaceuticals Inc.
Who Prioritizes Innovation? R&D Spending Compared for Takeda Pharmaceutical Company Limited and Supernus Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Biogen Inc. and Supernus Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Viatris Inc. and ACADIA Pharmaceuticals Inc.
Who Prioritizes Innovation? R&D Spending Compared for Viatris Inc. and Supernus Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Jazz Pharmaceuticals plc and Supernus Pharmaceuticals, Inc.
R&D Insights: How Corcept Therapeutics Incorporated and Supernus Pharmaceuticals, Inc. Allocate Funds
Analyzing R&D Budgets: Apellis Pharmaceuticals, Inc. vs Supernus Pharmaceuticals, Inc.
Analyzing R&D Budgets: Supernus Pharmaceuticals, Inc. vs Viridian Therapeutics, Inc.